Clinic
Poudre Valley Health Care INC.
Poudre Valley Health Care INC. was paid $1.29M by Medicaid between Apr 2019 and Dec 2024, across 32 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 48% of everything it billed.
33Billing provider infoPOUDRE VALLEY HEALTH CARE INC.
FORT COLLINS, CO 80528
FORT COLLINS, CO 80528
33aNPI1114586278assigned 06/11/2019
33bProvider typeEmergency Care Clinic/Center
28Total paid$1.29M
24GClaims27,858
24DCodes billed32
24AFirst – last monthApr 2019 – Dec 2024
Compared with peers
Next to other Emergency Care Clinic/Center providers in Colorado
Rank by total paid#12 of 23
Median peer was paid$1.29M
This provider vs. median1.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official CONCORDIA, ELIZABETH controls 15+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 202 | $4K | |
| 2020 | 3,926 | $198K | |
| 2021 | 11,457 | $450K | |
| 2022 | 8,767 | $443K | |
| 2023 | 2,953 | $144K | |
| 2024incomplete | 553 | $48K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 48% | 10,037 | 9,034 | $614K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 31% | 3,000 | 2,700 | $404K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 12% | 7,409 | 6,640 | $150K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.8% | 311 | 298 | $23K |
| 86769 | 1.3% | 411 | 395 | $17K | |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 1.1% | 107 | 95 | $14K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1.1% | 123 | 114 | $14K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 315 | 279 | $9K |
| 86140 | <1% | 439 | 406 | $8K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 94 | 91 | $6K |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,531 | 1,372 | $4K |
| 80053 | Comprehensive metabolic panel | <1% | 272 | 252 | $4K |
20 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 473 | $4K |
| 84481 | <1% | 210 | $3K | |
| 82607 | <1% | 292 | $2K | |
| 85652 | <1% | 453 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 216 | $2K |
| 80047 | <1% | 219 | $2K | |
| 84439 | <1% | 322 | $1K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 36 | $1K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 280 | $1K |
| 84466 | <1% | 15 | $384.17 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 15 | $330.00 |
| 84480 | <1% | 113 | $254.24 | |
| 82728 | <1% | 15 | $185.11 | |
| J3490 | Unclassified drugs | <1% | 771 | $131.06 |
| 80061 | Lipid panel | <1% | 13 | $102.70 |
| 83540 | <1% | 15 | $100.50 | |
| 85027 | <1% | 234 | $40.31 | |
| 81003 | <1% | 93 | $23.05 | |
| 81025 | <1% | 12 | $8.61 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCONCORDIA, ELIZABETH (PRESIDENT/CEO, UCHEALTH)
Parent organizationPOUDRE VALLEY HEALTH CARE INC.
| Provider | Location | Paid |
|---|---|---|
| University of Colorado Hospital Authority | Aurora, CO | $58.11M |
| Poudre Valley Health Care INC. | Fort Collins, CO | $19.97M |
| Poudre Valley Health Care INC | Windsor, CO | $11.80M |
| University of Colorado Hospital Authority | Aurora, CO | $3.82M |
| University of Colorado Hospital Authority | Arvada, CO | $1.37M |
| Poudre Valley Health Care INC | Windsor, CO | $1.16M |
| University of Colorado Hospital Authority | Thornton, CO | $800K |
| University of Colorado Hospital Authority | Commerce City, CO | $685K |
| Poudre Valley Health Care INC. | Fort Collins, CO | $441K |
| Poudre Valley Health Care INC. | Aurora, CO | $185K |
| Poudre Valley Health Care INC | Greeley, CO | $136K |
| University of Colorado Hospital Authority | Denver, CO | $2K |
| University of Colorado Hospital Authority | Denver, CO | $1K |
| University of Colorado Hospital Authority | Denver, CO | $409.85 |
| University of Colorado Hospital Authority | Lone Tree, CO | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.